Futu News reported on December 30 that on the second-to-last trading day of 2025, six new stocks were listed on the Hong Kong Stock Exchange, including 'an artificial intelligence (AI)-driven drug discovery and development company', $INSILICO (03696.HK)$ 'a Chinese digital twin technology company', $51WORLD (06651.HK)$ 'a provider of home robotics systems', $ONEROBOTICS (06600.HK)$ and a 'premium domestic skincare brand in China'. $FOREST CABIN (02657.HK)$ 'a Chinese data infrastructure and analytics company', $XUNCE (03317.HK)$ and 'a provider of prefabricated steel structure building services'. $USAS BUILDING (02671.HK)$ 。
The last time the Hong Kong Stock Exchange saw six bronze gongs being rung simultaneously was on July 9, including the listing of five new stocks, such as Lens Technology, and one ETF (Exchange-Traded Fund).index funds).
At the opening of today's Hong Kong stock market, Insilico Medicine surged by 45.53%, earning HKD 5,475 per lot; 51WORLD opened 14.75% higher, earning HKD 900 per lot; Meilian Shares rose by 15.63%, Linqingxuan increased by 9.3%, Xunce Technology gained 0.04%, and Anwa Robotics opened flat.
Insilico Medicine
Insilico Medicine is a leading enterprise in the global AI pharmaceuticals sector. Its core Pharma.AI platform empowers the entire drug discovery process. The average time required for candidate drugs to progress from target discovery to preclinical candidate confirmation is only 12-18 months, significantly shorter than the 4.5 years typically required by traditional methods. Its R&D efficiency leads the industry. Leveraging its generative AI technology advantages, it has produced over 20 assets at clinical or IND stages. Among these, its core candidate drug Rentosertib, used for treating idiopathic pulmonary fibrosis, has completed Phase 2a clinical trials with positive results, showing first-in-class potential. Its technical capabilities have been recognized by the industry, with related research findings published in authoritative journals such as the Journal of Medicinal Chemistry.
Insilico Medicine's pipeline covers multiple areas of unmet medical needs, including oncology, immunology, fibrosis, and metabolic disorders, forming a diversified portfolio. Core pipeline progress is leading, aside from Rentosertib. ISM4808, a PHD inhibitor for treating anemia associated with chronic kidney disease, has 'best-in-class' potential and has reached an exclusive licensing agreement for Greater China with TaiGen Biomedical, with a total transaction value reaching tens of millions of US dollars. To date, three assets have been licensed to international pharmaceutical companies, with contract values exceeding 2 billion US dollars, demonstrating initial commercialization potential.
Wuyi Vision
Wuyi Vision is a digital twin technology company based in China. The company has developed core competencies around three key areas of technological advancement: 3D graphics, simulation, and artificial intelligence. Founded in February 2015, the company’s founders observed that real-time 3D would become the most effective mode of information interaction following text, images, and video, driven by significant growth in data volume and rapid advancements in information carriers. At the time, real-time 3D was mainly used in gaming to immerse users in virtual entertainment environments.
In light of continuous technological progress and an increasing focus on industry applications, the company has chosen to expand the scope of real-time 3D functionality into broader application areas. Leveraging its sharp industry insights and deep understanding, the company believes that creating a digital twin of Earth can be broken down into five essential elements (architecture, roads, vegetation, water bodies, and terrain) and five developmental stages (static world, dynamic world, semi-simulated world, fully simulated world, and digital twin world).
Lin Qingxuan
Linqingxuan is a premium domestic skincare brand in China, focusing on the anti-wrinkle and firming skincare market. It is renowned for its flagship brand Linqingxuan, which provides high-end skincare solutions based on camellia ingredients.
According to data from CIC Consulting, since initiating research on camellia-based skincare products in 2012, the company pioneered the concept of 'nourishing skin with oil' and developed a camellia facial essence oil. Dedicated to providing safe and effective skincare solutions, the company launched its first camellia essence oil in 2014, which laid the foundation for its core oil-based skincare product line. After more than a decade of development, the company has accumulated expertise in cellular-level anti-wrinkle essence oil. Based on total retail sales across all channels, the company’s camellia essence oil has ranked first among all facial essence oils nationwide for 11 consecutive years since 2014.
Metropoly Holdings
According to a Frost & Sullivan report, Meilian Shares provides integrated services, including project design and optimization, procurement, manufacturing, and installation of prefabricated steel structure buildings. This comprehensive approach enables the company to execute projects smoothly, offering tailored end-to-end system services to maximize efficiency and deliver exceptional value. Through comprehensive analysis and optimization of various project components, the company can provide integrated subcontracting services that not only meet specific customer needs but also enhance investment efficiency. This integrated business model is the company’s primary competitive advantage, ensuring reliable project delivery and high-quality services to customers across different regions and industries.
The industrial sector of the prefabricated steel structure building market is characterized by high entry barriers, stringent regulatory controls, and rigorous quality standards. The company has solidified its position in this highly competitive market through comprehensive top-tier domestic and international certifications. As one of the first enterprises to receive the Grade A Specialized Qualification Certificate for Light Steel Structure Engineering Design and the Construction Enterprise Qualification Certificate issued by the Shanghai Municipal Commission of Housing and Urban-Rural Development, the company also holds multiple advanced qualifications granted by institutions such as the China Construction Metal Structure Association and the China Steel Structure Association. In addition to domestic certifications, the company has obtained accreditations from authoritative international organizations including the American Institute of Steel Construction (AISC) and European Standards (EN). Only a select few companies worldwide that meet strict quality and safety standards and pass rigorous evaluations are eligible to receive these certifications.
Woan Robotics
Woan Robotics occupies a significant position in the development and manufacturing of home robotics system products. According to a Frost & Sullivan report, as of the latest practicable date, the company is a fully integrated home robotics system provider capable of achieving multi-product intelligent interconnection within its ecosystem. Based on the same source, the company ranks first globally among home robotics system providers in terms of retail sales in 2024, with a market share of 11.9%. The company's mission is to provide smarter and more convenient living experiences for households through innovative technologies.
The company has assembled a highly specialized R&D team consisting of 278 members. Core team members hail from prestigious universities such as Harbin Institute of Technology, University of Toronto, and Peking University, and possess work experience at leading enterprises and institutions, including Google and the Centre for Advanced Robotics Technologies Innovation at Nanyang Technological University in Singapore. Adhering to the principle of product and innovation-driven development, the company continuously upgrades its self-developed technologies, ensuring seamless integration into its product offerings.
Xunce
Xunce is a supplier of real-time data infrastructure and analytical solutions in China. The company provides real-time IT solutions encompassing data infrastructure and data analysis for enterprises across all industries. Its system integration services facilitate seamless deployment within client-owned environments, including self-managed cloud and on-premises systems.
In 2024, the market value of China's real-time data infrastructure and analytics sector amounted to RMB 18.7 billion, accounting for 4.5% of China’s total data infrastructure and analytics market. By revenue, the company ranks fourth in this segment with a market share of 3.4%. In 2024, asset management accounted for 11.2% of China’s real-time data infrastructure and analytics market. Based on 2024 revenue, the company holds the top position in China’s asset management industry for real-time data infrastructure and analytics, with a market share of 11.6%.
Don't miss out on the IPO surge! The trailing stop order feature can help you lock in profits automatically.
The core functionality lies in 'moving the stop-loss based on market prices.' Simply put: when the stock price rises, your stop-loss line rises accordingly; when the stock price falls, the stop-loss line remains unchanged, and if it drops below the percentage you set, the system will automatically sell for you!
Editor/Lambor